Showing results (281-290 of 323) with videos related to
Sort By:
Pageof 33
Clinical Lung Cancer|December 3, 2014
Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trialMarcello Tiseo, Luca Boni, Francesca Ambrosio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibF Cappuzzo, L Toschi, G Tallini, et al.British Journal of Cancer|July 30, 2005
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II studyP F Conte, S Donati, A Gennari, et al.Brain : a Journal of Neurology|February 9, 2022
NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination and seizure thresholdPhilip H Iffland, Mariah E Everett, Katherine M Cobb-Pitstick, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Perspectives of novel imaging techniques for staging, therapy response assessment, and monitoring of surveillance in lung cancer: summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging WorkshopThomas Henzler, Peter Goldstraw, Frederik Wenz, et al.Trends in Ecology & Evolution|January 13, 2021
Integrating Mitochondrial Aerobic Metabolism into Ecology and EvolutionRebecca E Koch, Katherine L Buchanan, Stefania Casagrande, et al.Journal of the National Cancer Institute|May 5, 2005
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancerFederico Cappuzzo, Fred R Hirsch, Elisa Rossi, et al.Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesT Le Chevalier, G Scagliotti, R Natale, et al.The Lancet. Oncology|October 19, 2016
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 studyGlenwood Goss, Chun-Ming Tsai, Frances A Shepherd, et al.Epilepsia|February 8, 2014
Is focal cortical dysplasia sporadic? Family evidence for genetic susceptibilityRichard J Leventer, Floor E Jansen, Simone A Mandelstam, et al.Pageof 33